Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2697

Actual shortage: 241 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2447 (91%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

26 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-AMLODIPINE 5MG TABLET Resolved 2017-08-01 2018-03-13 17847
TEVA-AMLODIPINE 10MG TABLET Resolved 2017-08-01 2018-03-13 17850
TEVA-AMLODIPINE 10MG TABLET Resolved 2017-08-21 2018-03-13 19925
TEVA-AMLODIPINE 5MG TABLET Resolved 2020-05-01 2020-07-10 113794
TEVA-AMLODIPINE 10MG TABLET Resolved 2020-05-01 2020-07-10 113797
TEVA-AMLODIPINE 10MG TABLET Resolved 2020-05-08 2020-07-10 114442
TEVA-AMPHETAMINE XR 25MG CAPSULE (EXTENDED RELEASE) Resolved 2022-02-17 2022-04-21 155134
TEVA-AMPHETAMINE XR 30MG CAPSULE (EXTENDED RELEASE) Resolved 2022-02-24 2022-04-21 155563
TEVA-AMPHETAMINE XR 5MG CAPSULE (EXTENDED RELEASE) Resolved 2022-05-12 2022-07-01 160420
TEVA-AMPHETAMINE XR 20MG CAPSULE (EXTENDED RELEASE) Resolved 2022-08-18 2022-10-29 167226
TEVA-AMPHETAMINE XR 10MG CAPSULE (EXTENDED RELEASE) Resolved 2022-10-17 2023-07-28 172027
TEVA-AMPHETAMINE XR 30MG CAPSULE (EXTENDED RELEASE) Resolved 2023-02-02 2023-09-07 183419
TEVA-AMPHETAMINE XR 5MG CAPSULE (EXTENDED RELEASE) Resolved 2023-02-09 2023-07-28 184219
TEVA-AMPHETAMINE XR 25MG CAPSULE (EXTENDED RELEASE) Resolved 2023-02-09 2023-11-30 184222
TEVA-AMPHETAMINE XR 15MG CAPSULE (EXTENDED RELEASE) Resolved 2023-04-27 2023-08-18 190755
TEVA-AMPHETAMINE XR 20MG CAPSULE (EXTENDED RELEASE) Resolved 2023-04-27 2023-07-28 190758
TEVA-AMPHETAMINE XR 15MG CAPSULE (EXTENDED RELEASE) Resolved 2023-06-16 2023-07-06 195130
TEVA-AMPHETAMINE XR 30MG CAPSULE (EXTENDED RELEASE) Resolved 2023-06-16 2023-07-05 195139
TEVA-AMPHETAMINE XR 20MG CAPSULE (EXTENDED RELEASE) Resolved 2023-06-19 2023-07-05 195594
TEVA-AMPHETAMINE XR 25MG CAPSULE (EXTENDED RELEASE) Resolved 2023-06-20 2023-07-05 195778

Showing 641 to 660 of 2697

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-10-25 2019-10-26 97251
NOVAMOXIN 250MG CAPSULE Discontinued 2020-01-24 2020-01-24 104289
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63955
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63959
NOVASEN 650MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63964
NOVO-PROFEN 400MG TABLET Discontinued 2018-10-19 2018-10-19 64920
NOVO-PROFEN 200MG TABLET Discontinued 2019-04-11 2019-04-11 81310
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.375G 3G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210191
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.5G 4G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210194
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64589
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64592
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64615
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64623
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626
RATIO-ATORVASTATIN Discontinued 2018-10-19 2018-10-19 64852
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-12 2018-10-12 63943
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-19 2018-10-19 64891
TEVA-LENOLTEC NO. 1 300MG 8MG 15MG TABLET Discontinued 2019-04-11 2019-04-11 81362
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64595
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64598

Showing 81 to 100 of 250